![](/img/cover-not-exists.png)
Cost effectiveness of omalizumab add-on to standard-of-care therapy in patients with uncontrolled severe allergic asthma in a Brazilian healthcare setting
Suzuki, Cibele, Lopes da Silva, Nilceia, Kumar, Praveen, Pathak, Purnima, Ong, Siew HwaLanguage:
english
Journal:
Journal of Medical Economics
DOI:
10.1080/13696998.2017.1333513
Date:
May, 2017
File:
PDF, 948 KB
english, 2017